• Our Solution
    • Physicians
    • Patients
  • About Artrya
    • Who we are
    • Leadership Team
    • Board of Directors
    • Careers
  • Investor Relations
    • Overview
    • ASX Announcements
    • Corporate Governance
    • Company Research
  • Contact Us
Request a demonstration

Quarterly Activities/Appendix 4C Cash Flow Report

Notification regarding unquoted securities – AYA

Notification regarding unquoted securities – AYA

Five year Strategic Agreement with Cone Health

Proposed issue of securities – AYA

Artrya Lodges Q-Submission

Quarterly Activities/Appendix 4C Cash Flow Report

Artrya Commences Commercial Operations in Australia

Issue of Shares on Exercise of Options and Cleansing Notice

Application for quotation of securities – AYA

Previous 1 2 3 4 5 Next

Precise diagnosis. Personalized treatment.
Preventative care.

Choose Artrya as your trusted clinical partner.

Contact us today
Coronary artery disease.
We see you.

Sign up to our newsletter

Request a Demo
Contact Us

About Artrya
Investor Relations

Location
1257 Hay Street, West Perth, 6005
Follow us
X
LinkedIn

Salix Coronary Anatomy is listed on the Australian Register of Therapeutic Goods, ID 347719.  Salix Coronary Anatomy USA product (K243038) is cleared in the USA. 
For the availability of Salix in the EU, UK, US or other jurisdictions, please contact us.

© 2025, Artrya. All rights reserved. Privacy Policy Terms and Conditions Indications for Use